Page 5 - Pharma Intelligence News Today

Informa said demand for live events in its North American and European markets had been stronger than anticipated, with rebooking numbers back at pre-pandemic levels.

Investegate announcements from Informa PLC, Result of AGM

Investegate announcements from Pharma Intelligence, Pharma Intelligence Appoints General Counsel, Chief Commercial Officer

NEW YORK, June 08, 2022announces the appointments of Vicky Harris as General Counsel and Jeff Huntsman as Chief Commercial Officer (CCO). Prior to joining Pharma Intelligence, Harris was the head of

4,109 industry-sponsored clinical trials have moved from Phase I through to Phase III/IV and have either reached completed trial status or reported primary endpoints during 2021

Pharma Intelligence, announces that Warburg Pincus has completed its acquisition of the business from Informa PLC, the international Academic Markets, B2B Markets and Digital Services Group

Less than 3% of rare diseases clinical trials include investigational sites in India, which is much lower than the figures for prevalent chronic diseases

Investegate announcements from Informa PLC, Completion of Pharma Intelligence divestment

Investegate announcements from Informa Business Intelligence, Completion of Pharma Intelligence Acquisition by Warburg Pincus From Informa PLC and Appointment of Executive Chair

Investegate announcements from Informa PLC, Total Voting Rights